TrialAmerican journal of hematology2020

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

David C Fajgenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.